In conclusion, Raman spectroscopy holds significant promise as an intraoperative tool to address key challenges in glioma surgery, including tumor delineation, glioma grading, glioma subtyping, IDH status determination and differentiation from other CNS lesions. The gene discussed is IDH1; the disease is central nervous system cancer.